Discussion about this post

User's avatar
Savagelucia's avatar

Interesting post. Yes, the new hires are vulnerable, but one of them worked in the last Trump administration, so we’ll see. I wish, though, that you had covered more deeply the issue of CHAI and regulatory capture. There are lots of people in this space who are experienced healthcare folk who disagree with CHAIs approach. Lastly, it’s important to remember the scope of ASTP/ONC regulatory authority, which is certified EHRs. They don’t regulate AI developed by health systems when that AI is not for sale to others, and I suspect their authority over AI developed by health systems for sale, or over providers who use their own data stores to develop AI outside of a certified EHR would certainly be questionable under Loper Bright.

And of course, a manufacturer of AI that is a device would certainly be liable under FDA standards.

I think it’s good the PSOs are involved—that’s the only way to elicit accurate information so improvements can be made, but the staffs at the PSOs will have to up their tech knowledge significantly

Expand full comment
1 more comment...

No posts